NYSE:STEMedical Equipment
Did STERIS’ (STE) Record Chemistries Bet and Dividend Hike Just Recast Its Earnings Narrative?
In early August 2026, STERIS plc reported first‑quarter fiscal 2027 results showing higher sales and earnings year on year, reaffirmed its full‑year outlook, approved its 21st consecutive annual dividend increase to US$0.69 per share, and announced a record US$600 million chemistries Center of Excellence in North Carolina that will consolidate manufacturing and distribution.
The combination of a large, long‑term investment in infection‑prevention chemistries, continued earnings growth, and...